TY - JOUR T1 - Deep Sequencing of 10,000 Human Genomes JF - bioRxiv DO - 10.1101/061663 SP - 061663 AU - Amalio Telenti AU - Levi C.T. Pierce AU - William H. Biggs AU - Julia di Iulio AU - Emily H.M. Wong AU - Martin M. Fabani AU - Ewen F. Kirkness AU - Ahmed Moustafa AU - Naisha Shah AU - Chao Xie AU - Suzanne C. Brewerton AU - Nadeem Bulsara AU - Chad Garner AU - Gary Metzker AU - Efren Sandoval AU - Brad A. Perkins AU - Franz J. Och AU - Yaron Turpaz AU - J. Craig Venter Y1 - 2016/01/01 UR - http://biorxiv.org/content/early/2016/07/01/061663.abstract N2 - We report on the sequencing of 10,545 human genomes at 30-40x coverage with an emphasis on quality metrics and novel variant and sequence discovery. We find that 84% of an individual human genome can be sequenced confidently. This high confidence region includes 91.5% of exon sequence and 95.2% of known pathogenic variant positions. We present thedistribution of over 150 million single nucleotide variants in the coding and non-coding genome. Each newly sequenced genome contributes an average of 8,579 novel variants. In addition, each genome carries in average 0.7 Mb of sequence that is not found in the main build of the hg38 reference genome. The density of this catalog of variation allowed us to construct highresolution profiles that define genomic sites that are highly intolerant of genetic variation. These results indicate that the data generated by deep genome sequencing is of the quality necessary for clinical use.Significance statement Declining sequencing costs and new large-scale initiatives towards personalized medicine are driving a massive expansion in the number of human genomes being sequenced. Therefore, there is an urgent need to define quality standards for clinical use. This includes deep coverage and sequencing accuracy of an individual’s genome, rather than aggregated coverage of data across a cohort or population. Our work represents the largest effort to date in sequencing human genomes at deep coverage with these new standards. This study identifies over 150 million human variants, a majority of them rare and unknown. Moreover, these data identify sites in the genome that are highly intolerant to variation - possibly essential for life or health. We conclude that high coverage genome sequencing provides accurate detail on human variation for discovery and for clinical applications. ER -